Birdwatch Note
2022-01-25 16:18:01 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Patient, Beware: Some States Still Pushing Ineffective Covid Antibody Treatments | https://khn.org/news/article/states-use-monoclonal-antibody-covid-treatment-ineffective-against-omicron/?utm_source=Poynter+Institute&utm_campaign=445859e9c2-01%2F24%2F2022+-+Covering+COVID-19&utm_medium=email&utm_term=0_26742a15dc-445859e9c2-428314914
Written by 366373F693BC4E1DCFE260C0035EAE1C
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1485973357808033796
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1486010477759053826
- noteId - 1486010477759053826
- participantId - 366373F693BC4E1DCFE260C0035EAE1C
- noteAuthorParticipantId -
- createdAtMillis - 1643127481294
- tweetId - 1485973357808033796
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable - BELIEVABLE_BY_MANY
- harmful - LITTLE_HARM
- validationDifficulty - EASY
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Patient, Beware: Some States Still Pushing Ineffective Covid Antibody Treatments | https://khn.org/news/article/states-use-monoclonal-antibody-covid-treatment-ineffective-against-omicron/?utm_source=Poynter+Institute&utm_campaign=445859e9c2-01%2F24%2F2022+-+Covering+COVID-19&utm_medium=email&utm_term=0_26742a15dc-445859e9c2-428314914
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2022-01-25 16:18:01 UTC (1643127481294) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
366373F693BC4E1DCFE260C0035EAE1C | ||
2022-01-25 16:18:01 UTC (1643127481294) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
E1E04E09D6ED9D696BBFC0FA97CC759AA0E68361CB54A67643D7206688D8CE54 |
Note Ratings
rated at | rated by | |
2022-01-25 13:43:19 -0600 | 038D3CEB938B58575E97A29178D65F43D226F536986BCB865DC5247B8034D04F | Rating Details |
2022-01-25 12:52:13 -0600 | 0838B7F05D99BBF1F3ECACC60B932970 | Rating Details |
2022-01-25 13:58:15 -0600 | 0B683F53A71314B5B037053E967D8B7476EE62CEC7C245474E462A3294BE2995 | Rating Details |
2022-01-25 11:04:08 -0600 | 108C2E91FDE055E0672905728313969ABECE5713C01A0204E417655950215CB5 | Rating Details |
2022-01-26 01:10:41 -0600 | 16CFB95C4212BA4358E6E43B5407FBF1 | Rating Details |
2022-01-25 12:18:07 -0600 | 1810D7C5219004B6B738AF27868A4D7B | Rating Details |
2022-01-25 19:10:09 -0600 | 19C1EB2BEE07D946784EFC991B75576DA8696D750C93A81446DA41079B1C446C | Rating Details |
2022-01-25 21:20:56 -0600 | 1BB0EEDF53546DB0216424FFA77BFE0990C36182F8CF21D3C077F5D27A4C02CE | Rating Details |
2022-01-25 14:48:31 -0600 | 217118C2622E78169BC7409A624345A3 | Rating Details |
2022-01-25 11:04:08 -0600 | 2D4D43CCE52F7B961B1BFE77332EDBAD | Rating Details |
2022-01-25 12:09:07 -0600 | 3094A735B3543F478B66FCAAF0CCE3D9 | Rating Details |
2022-01-25 13:43:19 -0600 | 319DC899E23BD57088D7BEB822C7DA96 | Rating Details |
2022-01-25 11:14:08 -0600 | 37CD0C3E91D05F26465F226C5E9AC65B3AF9706B445D4CAEC6D3301D49672BD1 | Rating Details |
2022-01-25 13:16:14 -0600 | 399F030EB7A317B23E340EC7BACE09D6 | Rating Details |
2022-01-25 12:53:07 -0600 | 3A085886E5F5279F0EA76E742979A713CB31A1F8B259AC5DD662857809BC65DC | Rating Details |
2022-01-25 10:37:41 -0600 | 3BA1F850BA9FEA2EBE5E1C32528718D8 | Rating Details |
2022-01-25 12:28:45 -0600 | 4195BDEA51FB338B90ABF7706449857059651CA3CC26FF9839B1BAE0DE43E261 | Rating Details |
2022-01-25 10:21:20 -0600 | 42FA8B1FF1CCC7664B499E65BA5538A9F6A15E29F17C3E16017EF54518E490A9 | Rating Details |
2022-01-25 11:03:32 -0600 | 4A5114D148EE9654CF0AEDD5B2188B8E5DF4A74FCD833CF5054D8AA6F324CFB1 | Rating Details |
2022-01-25 12:48:21 -0600 | 4A51F5E62C58612BBD1556394391AEDD97D38CAB3FCC6DE5AD0DB92CADCB8895 | Rating Details |
2022-01-25 21:20:56 -0600 | 4FD1E5ECC4997999F8F339237379605B | Rating Details |
2022-01-25 12:18:07 -0600 | 583A5F0BAC61EA5C99CE9BEA0CE5561BC31309E5E4A6BECEA4203382E0559D9C | Rating Details |
2022-01-25 15:13:38 -0600 | 60330D4C76A95B273F2602B1BBCBA08FBD9D9FBB700F384975B6E488D9A49D71 | Rating Details |
2022-01-25 13:38:55 -0600 | 63CDDC3FA6EC88994DD6398811E27D50 | Rating Details |
2022-01-25 12:53:07 -0600 | 66DAEFC6A636E5E768A5DDEDEDFBBCF8 | Rating Details |
2022-01-25 10:42:36 -0600 | 7064FCB427905CAE112BCC535978D3E1 | Rating Details |
2022-01-25 10:42:36 -0600 | 768C4C4EA7E7720283DD0F9889D728C4E17B575949BC8CFFC54ECE5EF81A8897 | Rating Details |
2022-01-25 10:32:20 -0600 | 83BA8990DD948934B690889E21CE1195 | Rating Details |
2022-01-25 11:14:08 -0600 | 8B87DACB6D9426278233D96E01277AA3 | Rating Details |
2022-01-25 10:21:20 -0600 | 9ADCE068136AAFBE6AE1BDF8C59322C1 | Rating Details |
2022-01-25 12:52:13 -0600 | 9DB61B6404AAF0A3724FC0FFCAB92BD2DE01C1E4F0FAA6D32FD374B1FDD74CEE | Rating Details |
2022-01-25 13:38:55 -0600 | 9EADA94CE00754DE2C8322C7DF16E984F3F7AF985DF025C869D6975E44317EE0 | Rating Details |
2022-01-25 11:13:46 -0600 | A063B7E6506D9C133CB6857D8F185D7C385D35253ED1000D82EB09525B88F2EF | Rating Details |
2022-01-25 22:49:05 -0600 | A3A24C733ED8F1DD7A0681A12E906520 | Rating Details |
2022-01-25 17:34:18 -0600 | A5DC382F8506194A1008AC8048D6B828 | Rating Details |
2022-01-25 11:39:18 -0600 | AE699D3B4A2F5123EFC4C28B76297B44F8E4F1E8DC349688F5D4E90CD568C7C6 | Rating Details |
2022-01-25 12:46:24 -0600 | AF934C25F166203469390A24451CD099F96F082280CBBF75ECFC42832220FF77 | Rating Details |
2022-01-25 21:48:42 -0600 | B2238E0FF46218ECB2A6BF386FE5C74C | Rating Details |
2022-01-25 11:39:18 -0600 | B2C7629F85EB917F27068351EA82BBD8 | Rating Details |
2022-01-25 10:37:41 -0600 | B4D09121C29C1B868A60DA612AD38EF73C0CE3C094F71FFC71C70F12026F3F01 | Rating Details |
2022-01-25 22:49:05 -0600 | B54BFBA7D4B17220B529AFCA387D6F73D9234AEB92724F267A5D56CF3CA64F21 | Rating Details |
2022-01-25 15:13:38 -0600 | BAF92DD81812AF90CC562CC9E9081CBE | Rating Details |
2022-01-25 12:28:45 -0600 | BC4019DCCD889F72E701E12A6D2D7FC8 | Rating Details |
2022-01-25 15:25:05 -0600 | BCE3367BCAFBFF99A308328D8BC09AFB | Rating Details |
2022-01-25 13:21:04 -0600 | BD22388395CA5B212CCC05C16D698F6129672364E72C1BCE8FD7E9DA8E93A885 | Rating Details |
2022-01-26 01:10:41 -0600 | C46BD788C8E4311935178446476A31C8A5E46D54482EE5DF1CDA14A30AFE51B8 | Rating Details |
2022-01-25 19:10:09 -0600 | C4813CDC7FD620CE504E9D033752CEBE | Rating Details |
2022-01-25 11:03:32 -0600 | C6A2BA2E45B6E485D8BE39C657FA2B73 | Rating Details |
2022-01-25 14:48:31 -0600 | CE04BF683859ABB54D2B920833CCE1C871DEC653E0E6F683FD477695D110A80E | Rating Details |
2022-01-25 14:49:43 -0600 | CE2884B17EDFCB4384DE0B9F2F60FADB49A73E8F80B2DB7C288C8EDB6DC2E500 | Rating Details |
2022-01-25 13:21:04 -0600 | D1309A25CFDB5DA593484F2EA70B2D67 | Rating Details |
2022-01-25 12:48:21 -0600 | D5C8379F1BBD4F4236D59A2550A5B669 | Rating Details |
2022-01-25 12:46:24 -0600 | D75F54EF6E52A24D19EE92276C0C404D | Rating Details |
2022-01-25 15:25:05 -0600 | D766846F0793F7186AD5EF9DD8568828A2818C5AFA196C63DD19D95E863AF5B9 | Rating Details |
2022-01-25 10:32:20 -0600 | D9178456B4D1165BD61CAC5A04E8796BF7CD08E8F2893E9B34B54D64A1CFE46D | Rating Details |
2022-01-25 13:58:15 -0600 | DA4507E4409ABAABB16D1F142ADEA36B | Rating Details |
2022-01-25 13:16:14 -0600 | DB5485CAF18DAEF5D67863569EEAB897728AE7883D590F0A1D3AC3464AB50AB3 | Rating Details |
2022-01-26 08:31:04 -0600 | DF221327D2A632E6A947BD6B21F411AA | Rating Details |
2022-01-25 12:09:07 -0600 | E8753CBCABF45C14AE47A7B9CFFF329ABC388ECF8E3D51D192E3F9F5C8C826B3 | Rating Details |
2022-01-25 21:48:42 -0600 | EC35876F20EFFDD4D69E8B17E8015AD38400185594DAFCFC0AD5D62B1F0B7A97 | Rating Details |
2022-01-25 11:13:46 -0600 | EC805BC2BACC185BAE920DA54547D361 | Rating Details |
2022-01-25 17:34:18 -0600 | ED1EFDA968F6D338E760E46F2FF18F4D1F0EBDC485B857FDB437DEB9C968B322 | Rating Details |
2022-01-26 08:31:04 -0600 | FE49E515B9DEA3F46A79C5161BA5353D953CB37BE1D803E48EDFE6ECCFE1C217 | Rating Details |
2022-01-25 14:49:43 -0600 | FF87CBB5FE42E70E60A459B81EB0CB29 | Rating Details |
2022-01-25 13:58:15 -0600 | Rating Details | |
2022-01-25 21:20:56 -0600 | Rating Details | |
2022-01-25 22:49:05 -0600 | Rating Details | |
2022-01-25 10:32:20 -0600 | Rating Details | |
2022-01-25 13:21:04 -0600 | Rating Details | |
2022-01-25 13:43:19 -0600 | Rating Details | |
2022-01-25 12:52:13 -0600 | Rating Details | |
2022-01-25 13:16:14 -0600 | Rating Details | |
2022-01-25 19:10:09 -0600 | Rating Details | |
2022-01-25 11:03:32 -0600 | Rating Details | |
2022-01-25 10:37:41 -0600 | Rating Details | |
2022-01-25 11:39:18 -0600 | Rating Details | |
2022-01-25 12:18:07 -0600 | Rating Details | |
2022-01-25 11:13:46 -0600 | Rating Details | |
2022-01-25 21:48:42 -0600 | Rating Details | |
2022-01-25 12:09:07 -0600 | Rating Details | |
2022-01-25 12:46:24 -0600 | Rating Details | |
2022-01-25 14:48:31 -0600 | Rating Details | |
2022-01-25 15:25:05 -0600 | Rating Details | |
2022-01-25 17:34:18 -0600 | Rating Details | |
2022-01-25 12:28:45 -0600 | Rating Details | |
2022-01-25 11:04:08 -0600 | Rating Details | |
2022-01-25 13:38:55 -0600 | Rating Details | |
2022-01-25 10:21:20 -0600 | Rating Details | |
2022-01-26 01:10:41 -0600 | Rating Details | |
2022-01-26 08:31:04 -0600 | Rating Details | |
2022-01-25 10:42:36 -0600 | Rating Details | |
2022-01-25 12:53:07 -0600 | Rating Details | |
2022-01-25 11:14:08 -0600 | Rating Details | |
2022-01-25 12:48:21 -0600 | Rating Details |